Brighten Optix (Taiwan) Analysis

6747 Stock  TWD 136.00  12.00  9.68%   
Brighten Optix is overvalued with Real Value of 128.73 and Hype Value of 136.0. The main objective of Brighten Optix stock analysis is to determine its intrinsic value, which is an estimate of what Brighten Optix is worth, separate from its market price. There are two main types of Brighten Optix's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Brighten Optix's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Brighten Optix's stock to identify patterns and trends that may indicate its future price movements.
The Brighten Optix stock is traded in Taiwan on Taiwan OTC Exchange, with the market opening at 09:00:00 and closing at 13:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Taiwan. Brighten Optix is usually not traded on Adjusted Holiday / Chinese New Year 's Eve, Chinese New Year 's Eve, Chinese New Year, Dragon Boat Festival, National Day of the Republic of China, Chinese New Year 2, Chinese New Year 3, Adjusted Holiday 1, Adjusted Holiday 2, Mid - autumn / Moon Festival. Brighten Stock trading window is adjusted to Asia/Taipei timezone.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Brighten Stock Analysis Notes

About 68.0% of the company shares are owned by insiders or employees . The book value of Brighten Optix was presently reported as 50.35. The company recorded earning per share (EPS) of 10.85. Brighten Optix last dividend was issued on the 4th of July 2022. The entity had 1000:1124 split on the 17th of July 2024. Brighten Optix Corporation researches and develops, manufactures, and sells specialty contact lenses in Taiwan and the Asia Pacific region. The company offers its products under the Ortho-K myopia management lens, HiClear gas permeable lens, Briomoist lens care systems, SynergEyes hybrid lens, and Large Diameter GP lens. BRIGHTEN OPTIX operates under Medical Devices classification in Taiwan and is traded on Taiwan OTC Exchange. For more info on Brighten Optix please contact the company at 886 2 2880 1778 or go to https://www.brightenoptix.com.tw.

Brighten Optix Investment Alerts

Brighten Optix is not yet fully synchronised with the market data
Brighten Optix generated a negative expected return over the last 90 days
About 68.0% of the company shares are owned by insiders or employees

Brighten Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.27 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Brighten Optix's market, we take the total number of its shares issued and multiply it by Brighten Optix's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Brighten Profitablity

Brighten Optix's profitability indicators refer to fundamental financial ratios that showcase Brighten Optix's ability to generate income relative to its revenue or operating costs. If, let's say, Brighten Optix is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Brighten Optix's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Brighten Optix's profitability requires more research than a typical breakdown of Brighten Optix's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.35 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.35 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.35.

Brighten Optix Predictive Daily Indicators

Brighten Optix intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Brighten Optix stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

About Brighten Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Brighten Optix prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Brighten shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Brighten Optix. By using and applying Brighten Stock analysis, traders can create a robust methodology for identifying Brighten entry and exit points for their positions.
Brighten Optix Corporation researches and develops, manufactures, and sells specialty contact lenses in Taiwan and the Asia Pacific region. The company offers its products under the Ortho-K myopia management lens, HiClear gas permeable lens, Briomoist lens care systems, SynergEyes hybrid lens, and Large Diameter GP lens. BRIGHTEN OPTIX operates under Medical Devices classification in Taiwan and is traded on Taiwan OTC Exchange.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Brighten Optix to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Crypto Correlations Now

   

Crypto Correlations

Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
All  Next Launch Module

Additional Tools for Brighten Stock Analysis

When running Brighten Optix's price analysis, check to measure Brighten Optix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brighten Optix is operating at the current time. Most of Brighten Optix's value examination focuses on studying past and present price action to predict the probability of Brighten Optix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brighten Optix's price. Additionally, you may evaluate how the addition of Brighten Optix to your portfolios can decrease your overall portfolio volatility.